Article

Infamous Inmate Mumia Abu-Jamal To Receive Treatment for Hepatitis C

After a prolonged court battle, Abu-Jamal will begin treatment for HCV in prison.

Former death-row inmate Mumia Abu-Jamal began treatment last week with expensive, blockbuster hepatitis C virus (HCV) drugs, after initially being denied treatment.

Two years ago, Abu-Jamal was hospitalized after falling into diabetic shock. It was then that he learned he had HCV, and his lawyers sued to improve his medical treatment.

Abu-Jamal filed a lawsuit against a prison policy that denies access to treatment with the HCV drugs unless an inmate has advanced liver damage. Although it was denied in September 2016, US District Judge Robert Mariani ruled In January that Abu-Jamal had a right to be treated with HCV antiviral drugs.

Corrections spokeswoman Amy Worden said inmates are prioritized for treatment based on disease progression, according to US News. Based on recent testing, Abu-Jamal is now eligible to receive treatment with these life-saving drugs.

Abu-Jamal is a former Black Panther who was on death row for 29 years for the 1981 murder of Philadelphia, PA police officer Daniel Faulkner. In 2011, his sentence was reduced to life without parole.

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication